Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Adapted Onco-Esthetics sessions.
- Who it may be relevant to
- Registry conditions: Oncology, Aerodigestive Tract Cancer, Suportive Care. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of Adapted Aesthetic Onco in Patients With Cancer of the Upper Aero-digestive Tract During Their Management [ŒUVRE (Adapted Aesthetic Onco Aero-digestive Tract)]
Overview
Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image. Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive. This study will assess the feasibility of oncoesthetics and describe any obstacles.
Detailed description
The majority of patients treated for VADS cancer come from disadvantaged socio-professional and family backgrounds. Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.
The French association for Oncological Support Care (SOS) defines socio-aesthetics as "the professional practice of aesthetic care adapted to people who are fragile or suffering as a result of an attack on their physical or psychological integrity, or in social distress". Priority patients for aesthetic care are those whose treatments have had an impact on body image (mutilating surgery, skin toxicities), and/or who are in a situation of social precariousness and suffer from a loss of self-esteem.
For patients suffering from VADS cancer, a population not usually in need of aesthetic care but in need of self-image restoration, an incentive program has been set up. Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.
This study will assess the feasibility of OAS for VADS cancer patients, and describe any obstacles.
Interventions
- Other Adapted Onco-Esthetics sessions
Patient will received three sessions of Adapted Onco-Esthetics
Primary outcome measures
- Evaluate, in patients treated for cancer of the upper aerodigestive tract, the impact of early treatment with Adapted Onco-Esthetics [Time frame: At each session (first , second and third). An interval of one to 4 weeks between 2 sessions is permitted]
Eligibility criteria
Inclusion criteria
- Patient aged 18 or over
- Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
- Patient due to start oncological treatment (recurrence authorized)
- Patient fluent in French.
- Affiliation with a social security scheme
- Signature of informed consent prior to any specific procedure linked to the study
- Treatment with curative intent
Exclusion criteria
- Breast-feeding or pregnant patient
- Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
- Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
- Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
France · 1 center
- Centre Francois Baclesse — Caen
Identifiers
NCT: NCT06959810 · OEUVRE